| 摘要 |
This invention relates to a pharmaceutical composition for inhibiting / reducing neointimal proliferation. This pharmaceutical composition consists of diphenyleneiodonium and/or its chemical equivalents either alone or in combination with any pharmaceutically effective compound capable of preventing restenosis. This composition is administered locally into the wall of the coronary artery during the percutaneous coronary intervention procedure.
|
